ornidazole has been researched along with Colitis, Ulcerative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Gao, YZ; Gou, LS; Huang, YQ; Huang, YX; Li, Y; Wang, XQ; Xie, J; Yao, RQ; Zhang, RJ | 1 |
1 other study(ies) available for ornidazole and Colitis, Ulcerative
| Article | Year |
|---|---|
The Potential Immunomodulatory Properties of Levornidazole Contribute to Improvement in Experimental Ulcerative Colitis.
Topics: Animals; Caveolin 1; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Gene Expression Regulation; Humans; Immunomodulating Agents; Interleukin-18; Interleukin-1beta; Macrophages; Mice; Ornidazole | 2021 |